Phreesia IPO
Phreesia provides patient intake and engagement platform solutions for healthcare providers, digitizing the patient check-in process and enabling better data collection and workflow optimization. The company's software helps medical practices and health systems improve operational efficiency while enhancing the patient experience.
What We Know
Phreesia went public in July 2019 on the New York Stock Exchange under ticker PHR, raising approximately $110 million. The company priced its IPO at $17 per share and has experienced significant growth as a public company, particularly benefiting from accelerated healthcare digitization during the COVID-19 pandemic. The stock has shown strong performance since going public, though with typical healthcare technology volatility. Phreesia has expanded its platform capabilities and customer base substantially, adding new features around patient engagement, payment processing, and clinical workflows while maintaining strong recurring revenue growth.
Frequently Asked Questions
Has Phreesia had an IPO?
Yes, Phreesia completed its IPO in July 2019. The patient engagement platform company trades on the NYSE under ticker PHR.
When is the Phreesia IPO date?
Phreesia already completed its IPO on July 18, 2019. The company raised approximately $110 million in the public offering.
How can I buy Phreesia stock?
You can buy Phreesia stock through any brokerage account as it trades on the NYSE under ticker PHR. The stock has been publicly available since 2019.
Don't Miss the Next Big IPO
Get notified when the next major company files for an IPO. Daily alerts delivered to your inbox.
Get IPO Alerts